ES544862A0 - Un metodo para preparar un compuesto de morfolinol - Google Patents

Un metodo para preparar un compuesto de morfolinol

Info

Publication number
ES544862A0
ES544862A0 ES544862A ES544862A ES544862A0 ES 544862 A0 ES544862 A0 ES 544862A0 ES 544862 A ES544862 A ES 544862A ES 544862 A ES544862 A ES 544862A ES 544862 A0 ES544862 A0 ES 544862A0
Authority
ES
Spain
Prior art keywords
preparing
morpholinol
compound
morpholinol compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544862A
Other languages
English (en)
Other versions
ES8609286A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8609286A1 publication Critical patent/ES8609286A1/es
Publication of ES544862A0 publication Critical patent/ES544862A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES544862A 1984-07-05 1985-07-04 Un metodo para preparar un compuesto de morfolinol Expired ES8609286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848417170A GB8417170D0 (en) 1984-07-05 1984-07-05 Heterocyclic pharmaceutical compounds

Publications (2)

Publication Number Publication Date
ES8609286A1 ES8609286A1 (es) 1986-07-16
ES544862A0 true ES544862A0 (es) 1986-07-16

Family

ID=10563453

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544862A Expired ES8609286A1 (es) 1984-07-05 1985-07-04 Un metodo para preparar un compuesto de morfolinol

Country Status (12)

Country Link
EP (1) EP0170430A1 (es)
JP (1) JPS6124578A (es)
KR (1) KR860001083A (es)
AU (1) AU4459585A (es)
DK (1) DK307385A (es)
ES (1) ES8609286A1 (es)
FI (1) FI852657A7 (es)
GB (1) GB8417170D0 (es)
GR (1) GR851645B (es)
HU (1) HUT39437A (es)
IL (1) IL75720A0 (es)
ZA (1) ZA855072B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
BR9907203A (pt) 1998-01-21 2000-10-17 Glaxo Group Ltd "composto, composições farmacêuticas, uso de um composto, e, processo de tratametno de depressão, distúrbio de hiperatividade por deficiência de atenção (adhd), obesidade, enxaqueca, dor, disfunção sexual, doença de parkinson, doença de alzeheimer, ou vìcio de cocaìna ou de produtos contendo nicotina (especialmente tabaco) em um indivìduo animal ou humano. "
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
CA2800220C (en) 2010-05-21 2019-04-30 Research Triangle Institute Phenylmorpholines and analogues thereof
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
JPS6124578A (ja) 1986-02-03
ES8609286A1 (es) 1986-07-16
GB8417170D0 (en) 1984-08-08
EP0170430A1 (en) 1986-02-05
KR860001083A (ko) 1986-02-22
DK307385A (da) 1986-01-06
FI852657L (fi) 1986-01-06
HUT39437A (en) 1986-09-29
AU4459585A (en) 1986-01-09
FI852657A7 (fi) 1986-01-06
FI852657A0 (fi) 1985-07-04
DK307385D0 (da) 1985-07-04
GR851645B (es) 1985-11-26
IL75720A0 (en) 1985-11-29
ZA855072B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
ES542023A0 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES551515A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES553612A0 (es) Un procedimiento para preparar derivados de alanil-prolina.
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES551064A0 (es) Un metodo para preparar derivados de cefem
ES553666A0 (es) Un metodo para preparar nuevos derivados de cefem
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES550466A0 (es) Un metodo para preparar derivados de 9-bencilpurina
ES529034A0 (es) Un metodo para preparar nuevos compuestos de benzoilurea
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa
ES545130A0 (es) Un procedimiento para preparar un compuesto de piridoben- zodiazepina
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina
ES546669A0 (es) Un procedimiento para preparar compuestos relacionados con histargina
ES555853A0 (es) Un metodo para producir derivados de bromodicloroimidazol
ES550081A0 (es) Procedimiento para preparar un derivado de pirrolidina
ES555584A0 (es) Un metodo para producir n-desacetil-antibiotico tan-588